menu
    • menu

    Company profile for Merus

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical studies to have similar features as conventional monoclonal antibodies, such as long half-life and low immunogenicity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MerusNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Yalelaan 62, 3584 CM Utrecht
    Telephone
    Telephone
    +1 617 401 4499
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://merus.nl/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/merus/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MerusNV?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merus, Halozyme Sign Global Pact to Develop Petosemtamab
    Merus, Halozyme Sign Global Pact to Develop Petosemtamab

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/merus-and-halozyme-enter-global-collaboration-and-license-agreement-to-develop-subcutaneous-formulation-of-petosemtamab-302616859.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Merus’ Petosemtamab Shows Strong Activity in Metastatic CRC
    Merus’ Petosemtamab Shows Strong Activity in Metastatic CRC

    24 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/24/3172890/37568/en/Merus-Interim-Data-on-Petosemtamab-in-Metastatic-Colorectal-Cancer-Demonstrates-Monotherapy-Activity-and-Robust-Response-Rate-in-Combination-with-FOLFOX-FOLFIRI-with-Well-Tolerated.html

    GLOBENEWSWIRE
    24 Oct 2025
    Share Share
    Genmab Initiates Tender Offer For Merus N.V. Shares
    Genmab Initiates Tender Offer For Merus N.V. Shares

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3170170/0/en/Genmab-Commences-Tender-Offer-for-All-Issued-and-Outstanding-Common-Shares-of-Merus-N-V.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Merus Publishes Abstract on Petosemtamab in mCRC at AACR-NCI
    Merus Publishes Abstract on Petosemtamab in mCRC at AACR-NCI

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166055/37568/en/Merus-Announces-Publication-of-an-Abstract-on-Petosemtamab-in-Metastatic-Colorectal-Cancer-at-the-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeuti.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Merus To Present Petosemtamab Data In mCRC At AACR-NCI-EORTC
    Merus To Present Petosemtamab Data In mCRC At AACR-NCI-EORTC

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165684/37568/en/Merus-Announces-Petosemtamab-in-Metastatic-Colorectal-Cancer-Abstract-Selected-for-Plenary-Session-Oral-Presentation-at-the-AACR-NCI-EORTC-International-Conference-on-Molecular-Tar.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    Genmab Acquires Merus, Boosts Late-Stage Pipeline
    Genmab Acquires Merus, Boosts Late-Stage Pipeline

    30 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250928964515/en/Genmab-to-Acquire-Merus-Expanding-Late-Stage-Pipeline-and-Accelerating-into-a-Wholly-Owned-Model

    BUSINESSWIRE
    30 Sep 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search